Novo Nordisk A/S

Novo Nordisk A/S

NVO · NYSE
NVO · NYSE
37.82
USD-1.09-2.81%

Latest News

    @Investingcom
    Investingcom

    *NOVO NORDISK STARTS MULTI-MONTH SUBSCRIPTION PROGRAM FOR WEGOVY $NVO https://t.co/mM14BZXQB3

      @Investingcom
      Investingcom

      *NOVO AND HIMS END FEUD, WILL SELL OBESITY DRUGS TOGETHER $NVO $HIMS https://t.co/RvbLhOWfuZ

        @Investingcom
        Investingcom

        *NOVO NORDISK TO CUT OZEMPIC, WEGOVY'S US LIST PRICES BY UP TO 50%: WSJ $NVO https://t.co/fBJ05M6MNr

          @MarketRebels
          MarketRebels

          STARTS NOW! Rebel's Edge 1pm 🕐 $VNDA $ACLX $NVO $DPZ 🏈 NAJARIAN SPORTS 🏴‍☠️ with @petenajarian Winter Olympics: Hockey Finals was scripted perfectly, but did it reach 1980 levels? NFL: Chicago Bears, will they need to change the team's name? Indiana looking to build a Dome, NW https://t.co/CUnDFsQQz7

            @Investingcom
            Investingcom

            *NOVO NORDISK SINKS 15% AFTER WEIGHT LOSS DRUG FAILS TO MATCH ELI LILLY'S IN TRIAL $NVO $LLY https://t.co/xRsnosJ0yS

              SeekingAlpha

              4 stocks to watch on Monday: LLY, NVO, APO, TTE

              Hold

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              37.75USD
              39.12USD

              52 Week Range

              35.12USD
              64.16USD

              Market Cap

              171.31BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NYSE

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US6701002056

              CUSIP

              670100205

              Sector

              Healthcare

              Industry

              Drug Manufacturers - General

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              9.55

              PEG Ratio

              4.06

              Book Value

              7.42

              Dividend Share

              11.7

              Dividend Yield

              4.75%

              Earnings Share

              3.96

              Wall Street Target Price

              45.69

              EPS Estimate Current Year

              23.67

              EPS Estimate Next Year

              23.37

              EPS Estimate Current Quarter

              4.6207

              EPS Estimate Next Quarter

              4.308

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              333,650,001,920

              Gross Profit TTM

              278,039,003,136

              EBITDA

              181,555,003,392

              Profit Margin

              33.92%

              Return On Assets TTM

              19.05%

              Return On Equity TTM

              58.38%

              Revenue Per Share TTM

              75.248

              Qtly Revenue Growth YOY

              5.60%

              Diluted Eps TTM

              3.96

              Qtly Earnings Growth YOY

              -15.80%

              Valuation

              Trailing PE

              9.55

              Forward PE

              11

              Price Sales TTM

              0.4996

              Price Book MRQ

              5.3484

              Enterprise Value Revenue

              3

              Enterprise Value EBITDA

              7

              Peers analysis

              • Johnson & Johnson
                JNJJohnson & Johnson

                270.72

                1.26%
              • AbbVie Inc
                ABBVAbbVie Inc

                286.40

                1.04%
              • Merck & Company Inc
                MRKMerck & Company Inc

                133.75

                0.66%
              • Novartis AG
                NVSEFNovartis AG

                152.00

                -2.88%
              • Roche Holding AG Participation
                RHHVFRoche Holding AG Participation

                471.42

                -1.79%
              • Roche Holding AG
                RHHBFRoche Holding AG

                470.55

                -1.60%
              • Roche Holding Ltd ADR
                RHHBYRoche Holding Ltd ADR

                58.46

                -0.92%
              • AstraZeneca PLC
                AZNAstraZeneca PLC

                173.83

                -0.87%
              • Novartis AG ADR
                NVSNovartis AG ADR

                150.00

                -0.82%
              • Eli Lilly and Company
                LLYEli Lilly and Company

                1346.12

                -0.47%

              FAQs

              What is Novo Nordisk A/S stock price today?

              What is Novo Nordisk A/S stock ticker?

              Is NVO stock price going up?

              What is the analyst recommendation for NVO?

              What is NVO market cap?

              Does NVO release financial reports?

              When is NVO next earnings date?

              What were NVO Earnings for the last quarter?

              What was NVO Revenue for the last quarter?

              What was NVO Net Income for the last quarter?

              Does NVO pay dividends?

              How many employees does NVO have?

              What is NVO EBITDA?

              How to buy NVO stocks?

              Should I invest in NVO stock?